Michael R. Reich

Michael R. ReichMichael R. ReichMichael R. Reich
  • Home
  • About
  • Publications
  • HS&R Journal
  • Projects
    • Takemi Program Int Health
    • Rethinking Chagas
    • Rethinking Malaria
    • PolicyMaker Software
  • Courses
    • Harvard Courses
    • Flagship Course HSR
    • Cases in Global Health
    • MalariaX
  • Media
  • Contact
  • More
    • Home
    • About
    • Publications
    • HS&R Journal
    • Projects
      • Takemi Program Int Health
      • Rethinking Chagas
      • Rethinking Malaria
      • PolicyMaker Software
    • Courses
      • Harvard Courses
      • Flagship Course HSR
      • Cases in Global Health
      • MalariaX
    • Media
    • Contact

Michael R. Reich

Michael R. ReichMichael R. ReichMichael R. Reich
  • Home
  • About
  • Publications
  • HS&R Journal
  • Projects
    • Takemi Program Int Health
    • Rethinking Chagas
    • Rethinking Malaria
    • PolicyMaker Software
  • Courses
    • Harvard Courses
    • Flagship Course HSR
    • Cases in Global Health
    • MalariaX
  • Media
  • Contact

Rethinking Malaria Strategy in the Context of COVID–19

Progress in reducing the world’s malaria burden has plateaued in recent years, after fifteen years of progressive reductions that resulted in an overall 50% decline in burden and deaths. The ongoing COVID-19 pandemic has created new challenges for the global malaria strategy and for the human and financial resources and the delivery of essential malaria services within malaria-endemic countries. 


In 2021, Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative (under the direction of Professor Dyann Wirth) has convened a global engagement focused on “Rethinking Malaria Strategy in the Context of COVID–19” in partnership with the World Health Organization. This project seeks to take stock—What lessons have we learned from earlier successes with malaria that apply to our current context? Where have our approaches fallen short? What are the most important next steps in addressing global malaria?


The goal of “Rethinking Malaria Strategy in the Context of COVID–19” is to identify novel ‘game-changing’ approaches to malaria, through the activities of three working groups and a global advisory committee.


Professor Reich has served as co-chair, with Dr. Speciosa Wandira Kazibwe (former Vice President of Uganda), of the project’s Working Group on Rethinking Malaria Governance. Other members of this group include: Jesse B. Bump (Harvard); Nii Ayite Coleman (Ghana); Anya L. Guyer (USA); Kelechi Ohiri (Nigeria); Jimmy Opigo (Uganda), Ravindra Rannan-Eliya (Sri Lanka). 


The Working Group has produced six background papers related to Rethinking Malaria Governance available via Harvard’s central, open-access research repository (individual links provided here):


  1. “Rethinking Governance of Malaria,” by Michael R. Reich, Speciosa Wandira Kazibwe, with Jesse B. Bump, Nii Ayite Coleman, Anya L. Guyer, Kelechi Ohiri, Jimmy Opigo, and Ravindra Rannan-Eliya 
  2. “Malaria in the Governance of District Health Systems: Engaging Communities and Local Authorities,” by Nii Ayite Coleman  
  3. “Rethinking Malaria: Governance Lessons from Other Disease Programs,” by Kelechi Ohiri, Ifeyinwa Aniebo, and Olufunmilayo Akinlade  
  4. “Malaria Financing,” by Ravi Rannan-Eliya
  5. “Decolonizing Malaria Governance,” by Jesse B. Bump and Ifeyinwa Aniebo
  6. “Rethinking Communications for Governance of Malaria Programs,” by Jimmy Opigo and Anya L. Guyer


Learn more

Additional information on “Rethinking Malaria Strategy in the Context of COVID–19” can be found on the project website:

Rethinking Malaria website

Michael R. Reich

Copyright © 2021 Michael R. Reich

This website uses cookies

This is only to analyze website traffic. By accepting the use of cookies, your data will be grouped with the data of all other users.

Accept